Amlodipine

CAS 88150-42-9 0 current records 3 historicalSmall Molecule

Who holds supplier records for Amlodipine? No organisation holds a current US Type II DMF or EU CEP for Amlodipine in the registers PharmaTek covers. A further 3 organisations have only historical (inactive) DMF filings.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Amlodipine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/amlodipine

Reading the evidence

  • No current DMF or CEP on record

    Only historical filings exist in the covered registers. Any of these organisations may or may not supply today; confirm directly.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Amlodipine expires 24 Feb 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (0)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Amlodipine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Not found in the covered registers (FDA DMF list, EDQM). This is not evidence that no supplier exists.

Need Amlodipine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Amlodipine are no longer active. These show a past filing, not current supply.

Show all 3 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (64 listed products contain Amlodipine). The latest listed patent expires 24 Feb 2041. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Amlodipine is a long-acting dihydropyridine calcium channel blocker used to treat high blood pressure and coronary artery disease. It works by relaxing the blood vessels, which allows blood to flow more easily.

Chemical identity

IUPAC name
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Canonical SMILES
CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
InChIKey
HTIQEAQVCYTUBX-UHFFFAOYSA-N
Synonyms
ckd-330 component amlodipine, hgp-0904, hgp0904

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Dihydropyridine Calcium Channel Blocker
Mechanism of action
Calcium Channel Antagonists
Chemical structure
Dihydropyridines

Therapeutic areas

CardiovascularHypertension

Record history

PharmaTek records which organisations hold a current DMF or CEP for Amlodipine every week, starting 23 Oct 2026. Additions and lapses will appear here from the next weekly release.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

What do the historical Amlodipine records mean?

3 organisations have only inactive Type II DMFs for Amlodipine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does the FDA Orange Book list patents for products containing Amlodipine?

Yes. The latest patent listed for an approved US product containing Amlodipine expires 24 Feb 2041, across 64 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Amlodipine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Amlodipine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.